Breast cancer is the leading cause of death among solid tumours in women, and its
incidence is increasing in the West. Adjuvant chemotherapy and hormonal treatment …

Diagnosis of breast lesions is routinely performed by the triple assessment of a specialised
surgeon, radiologist and pathologist. In this setting, fine-needle aspiration cytology (FNAC) …

Needle core biopsy (NCB), as part of triple assessment for preoperative evaluation and
diagnosis of breast cancer, is now considered as an established, highly accurate method for …

Accurate determination of estrogen receptor (ER), progesterone receptor (PgR), and human
epidermal growth factor receptor-2 (HER2) status was very important in selecting breast …

Breast core biopsy is one of the major nonoperative methods of diagnosis. Increasingly,
there is also a need to provide prognostic data to facilitate timely patient management. We …

The estrogen receptor (ER) is a regulator of cellular growth, proliferation, and differentiation.
In addition to having prognostic value, ER is the most important biologic marker of …

Background The management of breast disease has been greatly facilitated by the
technology of needle biopsy interventions, and over the past 30 years, this has evolved from …

Introduction Tumor cell proliferation in breast cancer is strongly prognostic and may also
predict response to chemotherapy. However, there is no consensus on counting areas or cut …

Background Several studies have assessed the concordance of estrogen receptor (ER) and
human epidermal growth factor receptor 2 (HER2) status between core needle biopsy (CNB) …

The objective of this analysis was to determine the accuracy of steroid receptor
measurement in large core needle biopsies compared with surgically removed specimens …